GSK1120212+GSK2141795 for Cervical Cancer

This study has suspended participant recruitment.
(Drug supply)
Sponsor:
Collaborators:
Novartis
National Comprehensive Cancer Network
Information provided by (Responsible Party):
Ursula A. Matulonis, MD, Dana-Farber Cancer Institute
ClinicalTrials.gov Identifier:
NCT01958112
First received: October 4, 2013
Last updated: June 12, 2015
Last verified: June 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: March 2020
  Estimated Primary Completion Date: July 2016 (Final data collection date for primary outcome measure)